The molecular cytogenetics market combines cytogenetics and molecular biology. Cytogenetics is the study of chromosomes, and molecular cytogenetics includes the use of in-situ hybridization techniques to further analyse genetic variants or modifications. Biology and medicine both heavily rely on the applications of molecular cytogenetics.
In particular in medical and cancer-related genetics, molecular cytogenetics examines the structural and functional organisation of the chromosomes and their nucleus, genomic variants, expression, and evolution, as well as chromosomal disorders.
Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-2031
According to projections, the market for molecular cytogenetics would generate US$ 2,761.9 million in 2022 and US$ 6,469.2 million from 2022 to 2032, growing at a CAGR of 8.9%. Growth is attributed to improvements in disease diagnosis methods, greater public awareness of viral diseases, and higher levels of government assistance globally. From 2016 to 2021, the market for enterprise key management showed a CAGR of 10.3%.
In molecular cytogenetics, techniques like fluorescence in situ hybridization (FISH) are used to visualise the entire genome or the most precise parts of the genome by labelling DNA probes with various coloured fluorescent tags. Additionally, in molecular cytogenetics, the entire genome is evaluated for alterations in the number of copies of the genome using the virtual karyotyping technique. One of the most trustworthy methods for studying chromosomes is FISH & GISH.
Global Molecular Cytogenetics Market: Drivers and Restraints
Molecular cytogenetics provides a scan and analysis of the whole genome organization, its structure and behavior at high resolutions and also the visualization of single peculiar genomic loci which is a major growth driver for the global molecular cytogenetics market.
The recent advances in the fields of molecular biology and cytogenetics have brought about several key developments in the research of mitosis and meiosis processes, chromosome structures and its subsequent manipulation, gene expression and its regulation, and gene silencing techniques. Molecular cytogenetics is primarily driven by cancer diagnostics which offers techniques for imaging in genetics, epigenetics, and cytology and can be utilized for chromosomal modifications.
Get a Customized Scope to Match Your Need Ask an Expert! https://www.futuremarketinsights.com/customization-available/rep-gb-2031
Global Molecular Cytogenetics Market: Regional Outlook
Geographically, the global molecular cytogenetics market is segmented into seven regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America & Western Europe are market leaders regarding revenue in the global molecular cytogenetics market owing to the presence of large number of clinical research laboratories and research & academic institutes. Japan is the third major contributor to the global molecular cytogenetics market mainly due to the well-established collaborations between the manufacturers and research laboratories.
Also, the role of personalized medicine in treatment of genetic or other disorders is gaining pace in the developed countries and this factor is anticipated to unfold novel opportunities for the key players during the forecast period. APEJ is anticipated to register healthy CAGR in the global molecular cytogenetics market due to a surge in the number of scientific researches being undertaken in this region. Middle East and Africa and Latin America are at nascent stages in the global molecular cytogenetics market and are projected to register steady growth rates during the forecast period.
Key Companies Profiled:
- Thermo Fisher Scientific Inc.
- GeneDx
- CytoTest Inc.
- Empire Genomics
- Abbott Laboratories
- Agilent Technologies
- Biological Industries
- PerkinElmer Inc.
- Bio-RAD Laboratories Inc.
- F. Hoffmann-La Roche AG
Immerse Yourself In The World Of Insightful Methodologies Today! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2031
Key Segments Profiled in the Molecular Cytogenetics Industry Survey
Global Molecular Cytogenetics Market by Technique Type:
- Genomic in Situ Hybridization (GISH)
- Fluorescence in Situ Hybridization (FISH)
- Multicolour Fluorescence in Situ Hybridization
- Multiplex Fluorescence in Situ Hybridization (M-FISH)
- Spectral Karyotyping (SKY)
- Comparative Genomic Hybridization (CGH)
- Array Comparative Genomic Hybridization
- Other Molecular Cytogenetic Techniques
Global Molecular Cytogenetics Market by Product Type:
- Instruments for Molecular Cytogenetics
- Reagents & Kits for Molecular Cytogenetics
Global Molecular Cytogenetics Market by End User:
- Molecular Cytogenetics in Pharmaceutical & Biotechnology Companies
- Molecular Cytogenetics in Clinical Research Laboratories
- Molecular Cytogenetics in Research & Academic Institutes
- Molecular Cytogenetics in Hospitals
- Molecular Cytogenetics in Diagnostic Centers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
